Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Cartography Biosciences, Inc.
Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
December 18, 2025
From
Cartography Biosciences, Inc.
Via
Business Wire
Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic
October 02, 2025
From
Cartography Biosciences, Inc.
Via
Business Wire
Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team
September 03, 2025
From
Cartography Biosciences, Inc.
Via
Business Wire
Cartography Unveils First Pipeline Program Targeting a Highly-Specific and Emerging Colorectal Cancer Antigen in Abstract Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
November 04, 2024
From
Cartography Biosciences, Inc.
Via
Business Wire
Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
October 29, 2024
From
Cartography Biosciences, Inc.
Via
Business Wire
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
May 28, 2024
From
Cartography Biosciences, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.